Literature DB >> 15644889

[Incidence of cancer in Navarre].

E Ardanaz1, C Moreno, M E Pérez de Rada Arístegui, C Ezponda, N Navaridas.   

Abstract

Between 1998 and 2000 an annual average of 3,303 cases of invasive cancer were registered in Navarre, 58% of them in men. If we except non melanoma skin tumours, the annual number of cases was 2,495, with gross incidence rates of 559 and 372 per 100,000 in men and women, and rates adjusted to the world population of 312 and 203 per 100,000 respectively. Amongst men, the four most frequently diagnosed tumoural localisations were the prostate, lung, colorectal and bladder, accounting for 57% of all cases. The most notable due to their frequency amongst women were tumours of the breast, colorectal, uterus body and ovary, accounting for 54% of all cases. With respect to the five year period from 1993 to 1997, the global incidence of cancer in the three year period from 1998 to 2000 has increased 4.2% in men and 7.4% in women. The incidence of lung cancer and non-Hodgkin lymphomas in both sexes and of breast cancer in women and prostate cancer in men are notable. There continues to be a fall in the incidence rates of stomach cancer in both sexes, following the tendency begun in the 1970s.

Entities:  

Mesh:

Year:  2004        PMID: 15644889     DOI: 10.4321/s1137-66272004000500008

Source DB:  PubMed          Journal:  An Sist Sanit Navar        ISSN: 1137-6627            Impact factor:   0.829


  2 in total

1.  Impact of radiotherapy on the quality of life of elderly patients with localized breast cancer. A prospective study.

Authors:  Juan Ignacio Arraras; Ana Manterola; Miguel Angel Domínguez; Fernando Arias; Elena Villafranca; Pilar Romero; Enrique Martínez; José Juan Illarramendi; Esteban Salgado
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

2.  Different regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race.

Authors:  Mitchell S Wachtel; Yan Zhang; Maurizio Chiriva-Internati; Eldo E Frezza
Journal:  BMC Cancer       Date:  2006-03-15       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.